Key result
Psychotropic drugs tend to be more potent, more toxic, or longer lasting among elderly mentally retarded persons due to age-related physiological and pharmacokinetic changes.
Physiological changes in aging make psychotropic drugs more potent and toxic in elderly mentally retarded persons, necessitating careful guidelines for their use.
May require adjusted psychotropic dosing in elderly patients with intellectual disability; leaves open prospective validation of recommendations.
Elderly people tend to be large consumers of medication in general and psychotropic drugs in particular. Sedative/hypnotics, anxiolytics, antidepressants, and neuroleptic drugs tend to be the most commonly used psychotropic medications among elderly people who are not developmentally disabled. These drugs are probably commonly employed among elderly mentally retarded people as well, although the rank order of use probably differs. A number of physiological changes which accompany greater age are described and the impact on pharmacokinetic variables outlined. Other factors associated with aging, which influence drug actions, are also outlined. The net effect appears to be that most drugs are more potent, more toxic, or longer lasting among the elderly. Data are also presented on tardive dyskinesia insofar as aging is concerned. This is followed by overall conclusions and some suggested guidelines for the use of these drugs in older mentally retarded persons.
No takes yet. Share an insight, caveat, or question.
M. G. Aman (1990) conducted a review in Mental retardation in the elderly. Psychotropic drugs was evaluated. Psychotropic drugs tend to be more potent, more toxic, or longer lasting among elderly mentally retarded persons due to age-related physiological and pharmacokinetic changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: